PALO ALTO, Calif., Dec. 3, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, ...

PALO ALTO, Calif., Oct. 22, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today ...

The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...

A new article could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes accelerated aging in ...

Sentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved in the U.S. (2020), ...

A ground-breaking online community has been launched to allow people with the rare disease Progeria to communicate regardless of their location or language. Progeria Connect, a new partnership between ...

19-year-old Beandri Booysen from South Africa, who battled the extremely rare Hutchinson-Gilford progeria syndrome, has sadly ...

A rare, but fatal genetic disease that accelerates aging in children, progeria, could soon have a cure, The New York Times reported July 24. The disease affects only 1 in every 4 million to 8 million ...

A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using ‘longevity genes’ found in people who live exceptionally long lives - over 100 years old.

(Gray News) – The longest-living survivor of progeria has died at the age of 28. In a Facebook post, the Progeria Research Foundation announced that Sammy Basso passed away Saturday. “Sammy was the ...